%0 Journal Article
%U http://www.molvis.org/molvis/v21/378
%> mv-v21-378.pdf
%A  Bagheri,  Abouzar
%A  Soheili,  Zahra-Soheila
%A  Ahmadieh,  Hamid
%A  Samiei,  Shahram
%A  Sheibani,  Nader
%A  Astaneh,  Shamila Darvishalipour
%A  Kanavi,  Mozhgan Rezaei
%A  Mohammadian,  Azam
%T Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells
%D 2015
%V 21
%P 378-390
%J Molecular Vision